Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 9.36%, near the low end of its 5-year range (0.00%–17.24%).
As of the fiscal period ended Tuesday, March 31, 2026. 100.00% below its 12-month average of 0.61%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.61%
DEBT TO ASSETS RATIO AVG 3Y
5.78%
DEBT TO ASSETS RATIO AVG 5Y
9.36%
DEBT TO ASSETS RATIO AVG 10Y
10.50%
DEBT TO ASSETS RATIO AVG 15Y
11.46%
DEBT TO ASSETS RATIO AVG 20Y
13.43%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
United Therapeutics Corporation
Market Cap
$22.23B
Debt to Assets Ratio
0.00%
TTM Avg
0.61%
3Y Avg
5.78%
5Y Avg
9.36%
Market Cap
$23.72B
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.77B
Debt to Assets Ratio
0.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.52B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $22.23B | 0.00% | 0.61% | 5.78% | 9.36% |
| Moderna, Inc. (MRNA)vs › | $22.14B | 0.16% | N/A | N/A | N/A |
| STERIS plc (STE)vs › | $22.45B | 0.19% | N/A | N/A | N/A |
| BioNTech SE (BNTX)vs › | $23.38B | 0.01% | N/A | N/A | N/A |
| Viatris Inc. (VTRS)vs › | $20.80B | 0.40% | N/A | N/A | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 0.10% | N/A | N/A | N/A |
| Waters Corporation (WAT)vs › | $25.02B | 0.29% | N/A | N/A | N/A |
| Labcorp Holdings Inc. (LH)vs › | $25.77B | 0.39% | N/A | N/A | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.52B | 0.33% | N/A | N/A | N/A |
| Incyte Corporation (INCY)vs › | $25.96B | 0.01% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.01
Current Ratio
6.60
Interest Coverage
77.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.48% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 2.58% |
| 2024-12-31 | 4.07% |
| 2024-09-30 | 5.62% |
| 2024-06-30 | 7.44% |
| 2024-03-31 | 9.24% |
| 2023-12-31 | 9.77% |
| 2023-09-30 | 11.39% |
| 2023-06-30 | 11.97% |
| 2023-03-31 | 12.61% |
| 2022-12-31 | 13.24% |
| 2022-09-30 | 13.84% |
| 2022-06-30 | 14.43% |
| 2022-03-31 | 14.93% |
| 2021-12-31 | 15.48% |
| 2021-09-30 | 15.85% |
| 2021-06-30 | 16.51% |
| 2021-03-31 | 17.24% |
| 2020-12-31 | 17.33% |
| 2020-09-30 | 18.14% |
| 2020-06-30 | 18.96% |
| 2020-03-31 | 19.87% |
| 2019-12-31 | 21.72% |
| 2019-09-30 | 25.00% |
| 2019-06-30 | 26.93% |
| 2019-03-31 | 28.37% |
| 2018-12-31 | 7.35% |
| 2018-09-30 | 7.33% |
| 2018-06-30 | 7.70% |
| 2018-03-31 | 8.28% |
| 2017-12-31 | 8.68% |
| 2017-09-30 | 8.51% |
| 2017-06-30 | 9.29% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.04% |
| 2016-03-31 | 0.25% |
| 2015-12-31 | 0.25% |
| 2015-09-30 | 1.39% |
| 2015-06-30 | 1.86% |
| 2015-03-31 | 6.08% |
| 2014-12-31 | 6.71% |
| 2014-09-30 | 14.06% |
| 2014-06-30 | 18.60% |
| 2014-03-31 | 13.67% |
| 2013-12-31 | 13.71% |
| 2013-09-30 | 14.69% |
| 2013-06-30 | 15.78% |
| 2013-03-31 | 16.36% |
| 2012-12-31 | 16.99% |
| 2012-09-30 | 16.59% |
| 2012-06-30 | 17.40% |
| 2012-03-31 | 17.17% |
| 2011-12-31 | 17.50% |
| 2011-09-30 | 19.04% |
| 2011-06-30 | 19.84% |
| 2011-03-31 | 20.80% |
| 2010-12-31 | 21.30% |
| 2010-09-30 | 20.51% |
| 2010-06-30 | 21.80% |
| 2010-03-31 | 22.60% |
| 2009-12-31 | 23.83% |
| 2009-09-30 | 24.54% |
| 2009-06-30 | 25.50% |
| 2009-03-31 | 26.45% |
| 2008-12-31 | 26.97% |
| 2008-09-30 | 32.61% |
| 2008-06-30 | 36.77% |
| 2008-03-31 | 39.18% |
| 2007-12-31 | 42.59% |
| 2007-09-30 | 48.76% |
| 2007-06-30 | 52.99% |
| 2007-03-31 | 57.31% |
| 2006-12-31 | 52.25% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.01% |
| 2005-12-31 | 0.01% |
| 2005-09-30 | 0.23% |
| 2005-06-30 | 0.35% |
| 2005-03-31 | 0.01% |
| 2004-12-31 | 0.01% |
| 2004-09-30 | 0.02% |
| 2004-06-30 | 0.02% |
| 2004-03-31 | 0.02% |
| 2003-12-31 | 0.44% |
| 2003-09-30 | 1.33% |
| 2003-06-30 | 1.53% |
| 2003-03-31 | 1.56% |
| 2002-12-31 | 1.02% |
| 2002-09-30 | 1.01% |
| 2002-06-30 | 0.95% |
